Atlas Trials

A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)

Clinical trial NCT05515367 · RECRUITING

Trial details

NCT number
NCT05515367
Sponsor
Zydus Lifesciences Limited
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Kidney DiseasesAnemia of Chronic Kidney Disease
Start date
2023-04-20
Primary completion
2025-06-30
Enrollment
1004

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.